Interview: John O’Hara – General Manager, Janssen Puerto Rico
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-in-class prescription medications and are poised to serve the broad needs of the healthcare market – from patients to practitioners, from clinics to hospitals.
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading Belgian researcher, pharmacologist, and general practitioner. Dr. Janssen led a group of researchers to discover a medicine that helped change the way mental health patients were treated. His company, Janssen Pharmaceutica, joined the Johnson & Johnson family of companies in 1961. Our company remains guided by Dr. Janssen’s values of excellence and innovation.
Contact details
Bo. Mamey
Carr. 933 Km 0.1
Gurabo, PR 00778-9629
USA
Tel : 787-272-7600
www.janssen.com
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
Sebastián Negrón Reichard, Secretary of the Department of Economic Development and Commerce, sees Puerto Rico’s current economic landscape as one of immense opportunity, particularly with the US government’s focus on…
Umberto Donato, president of DDD Group, a construction firm specialising in complex sectors including pharma, reflects on the company’s growth over the past decade and the role of infrastructure and…
Glorimar Torres, with over 33 years in the pharmaceutical industry, has had a diverse career, starting as a sales representative in Puerto Rico and progressing through key roles at companies…
At PMC, reinvention isn’t just a strategy—it’s our commitment to staying relevant, connected, and impactful in the lives of patients, professionals, and communities we serve. Ivelisse Casillas, founder of…
We are not only facilitating compliance, we are helping to rebuild confidence in Puerto Rico as a destination for medical careers. In a healthcare system strained by regulatory inertia and…
We’re not just reconnecting with our roots—we’re planting new ones. The PDA Puerto Rico chapter is a bridge between our island’s rich pharmaceutical legacy and a future powered by innovation,…
We’re not just building facilities—we’re building the future of medicine, where innovation is inclusive, access is equitable, and every breakthrough brings us closer to a healthier world. Biopharmaceutical innovation is…
Backed by world-class expertise, cutting-edge technology, and an ecosystem built on collaboration, the Medical Device Cluster is redefining what it means for Puerto Rico to be a global leader in…
Isla Frio provides state-of-the-art temperature-controlled storage solutions for pharma, among other industries. Founder Geoffrey Parrillo discusses the company’s efforts to adapt to the demands of the pharma industry, offering solutions such…
The industry’s growing reliance on outsourcing and flexible service models means that the consulting business, including ours, will continue to thrive. There is a strong market demand for specialised support,…
Añasco-based Techno Plastics Industries (TPI) is a Puerto Rican firm specializing in injection molding, producing high-quality plastic parts for industries like medical devices, electronics, and aerospace. Recently appointed General Manager,…
DECA is a consulting firm founded in 2022, focused on helping businesses in Puerto Rico access non-dilutive financing incentives, such as federal grants, local grants, and monetizable R&D tax credits.…
See our Cookie Privacy Policy Here
